Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beyond Proton Pump Inhibitors and Nissen Fundoplication: Minimally Invasive Alternatives for Gastroesophageal Reflux Disease.

Literature DB >> 35466305

Beyond Proton Pump Inhibitors and Nissen Fundoplication: Minimally Invasive Alternatives for Gastroesophageal Reflux Disease.

Reginald C W Bell¹.

Abstract

Entities: Chemical

Year: 2021 PMID： 35466305 PMCID： PMC9021164

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

Keyword Cloud
References

× No keyword cloud information.

8 in total

1. Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel.

Authors: Andrew J Gawron; Reginald Bell; Barham K Abu Dayyeh; F P Buckley; Kenneth Chang; Christy M Dunst; Steven A Edmundowicz; Blair Jobe; John C Lipham; Dan Lister; Marcia Irene Canto; Michael S Smith; Anthony A Starpoli; George Triadafilopoulos; Thomas J Watson; Erik Wilson; John E Pandolfino; Alexander Kaizer; Zoe Van De Voorde; Rena Yadlapati
Journal: Gastrointest Endosc Date: 2020-01-31 Impact factor: 9.427

2. Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized Trial.

Authors: Reginald Bell; John Lipham; Brian E Louie; Valerie Williams; James Luketich; Michael Hill; William Richards; Christy Dunst; Dan Lister; Lauren McDowell-Jacobs; Patrick Reardon; Karen Woods; Jon Gould; F Paul Buckley; Shanu Kothari; Leena Khaitan; C Daniel Smith; Adrian Park; Christopher Smith; Garth Jacobsen; Ghulam Abbas; Philip Katz
Journal: Clin Gastroenterol Hepatol Date: 2019-09-10 Impact factor: 11.382

3. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.

Authors: Reginald Bell; John Lipham; Brian Louie; Valerie Williams; James Luketich; Michael Hill; William Richards; Christy Dunst; Dan Lister; Lauren McDowell-Jacobs; Patrick Reardon; Karen Woods; Jon Gould; F Paul Buckley; Shanu Kothari; Leena Khaitan; C Daniel Smith; Adrian Park; Christopher Smith; Garth Jacobsen; Ghulam Abbas; Philip Katz
Journal: Gastrointest Endosc Date: 2018-07-18 Impact factor: 9.427

4. Lower Esophageal Sphincter Augmentation for Gastroesophageal Reflux Disease: The Safety of a Modern Implant.

Authors: C Daniel Smith; Robert A Ganz; John C Lipham; Reginald C Bell; David W Rattner
Journal: J Laparoendosc Adv Surg Tech A Date: 2017-04-21 Impact factor: 1.878

5. Objective outcomes 14 years after laparoscopic anterior 180-degree partial versus nissen fundoplication: results from a randomized trial.

Authors: Joris A Broeders; Emily A Broeders; David I Watson; Peter G Devitt; Richard H Holloway; Glyn G Jamieson
Journal: Ann Surg Date: 2013-08 Impact factor: 12.969

Beyond Proton Pump Inhibitors and Nissen Fundoplication: Minimally Invasive Alternatives for Gastroesophageal Reflux Disease.

1. Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel.

2. Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized Trial.

3. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.

4. Lower Esophageal Sphincter Augmentation for Gastroesophageal Reflux Disease: The Safety of a Modern Implant.

5. Objective outcomes 14 years after laparoscopic anterior 180-degree partial versus nissen fundoplication: results from a randomized trial.

6. Management of regurgitation in patients with gastroesophageal reflux disease.

Review 7. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease.

8. Transoral incisionless fundoplication demonstrates durability at up to 9 years.